[HTML][HTML] Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases
… PGx-guided treatment for the drugs clopidogrel and warfarin … PGx-guided clopidogrel
treatment was cost-effective in the … , this study did not specifically examine economic value, but …
treatment was cost-effective in the … , this study did not specifically examine economic value, but …
A systematic review of economic evaluations of advanced therapy medicinal products
H Lloyd‐Williams, DA Hughes - British journal of clinical …, 2021 - Wiley Online Library
… that ACI-P becomes more cost effective if the utility value of patients doing well … drug
development, or were analyses of hypothetical drugs with very limited (if any) evidence on treatment …
development, or were analyses of hypothetical drugs with very limited (if any) evidence on treatment …
[HTML][HTML] An updated systematic review of cost-effectiveness analyses of drugs for osteoporosis
… drugs were generally cost effective in comparison with no … It is worth noting that in the
scoring system we excluded … With emerging evidence about the value of sequential therapy […
scoring system we excluded … With emerging evidence about the value of sequential therapy […
[HTML][HTML] Cost-effectiveness of cancer drugs: Comparative analysis of the United States and England
… NICE stated treatment was not a cost-effective use of resources … that four drugs were deemed
cost-effective by ICER and valued … of evidence suggests that the drug can be considered …
cost-effective by ICER and valued … of evidence suggests that the drug can be considered …
Pharmaceuticals
G Salkeld, A Mitchell, S Hill - Economics and Australian health …, 2020 - taylorfrancis.com
… value; • if the drug has fallen into disuse or is no longer available; or • if treatment with the
drug is no longer deemed cost-effective … of evidence-based medicine, in which evidence-based …
drug is no longer deemed cost-effective … of evidence-based medicine, in which evidence-based …
[HTML][HTML] Challenges in synthesising cost-effectiveness estimates
GE Shields, J Elvidge - Systematic Reviews, 2020 - Springer
… to be cost effective, the uncertainty in the evidence base, and … with more than two alternatives
treatments, they may identify … used to vary the parameter values. When probabilistic results …
treatments, they may identify … used to vary the parameter values. When probabilistic results …
Prices and clinical benefit of cancer drugs in the USA and Europe: a cost–benefit analysis
KN Vokinger, TJ Hwang, T Grischott, S Reichert… - The Lancet …, 2020 - thelancet.com
… drugs have weak or uncertain evidence about their clinical … constrained health-care budgets,
the delivery of cost-effective … suggests that value frameworks could help identify drugs with …
the delivery of cost-effective … suggests that value frameworks could help identify drugs with …
Cost-effectiveness analyses of breast cancer medications use in developing countries: a systematic review
NH Al-Ziftawi, AA Shafie… - Expert review of …, 2021 - Taylor & Francis
… use of cancer treatment should be based on the value of the … evidence [Citation10]. There
are some published systematic … Some of the drugs that were proven to be cost-effective in …
are some published systematic … Some of the drugs that were proven to be cost-effective in …
Cost-effectiveness of interventions to manage diabetes: has the evidence changed since 2008?
… provides an updated understanding of the potential value of … technologies and medications
can provide evidence on how … judge whether an intervention is cost-effective, we grouped the …
can provide evidence on how … judge whether an intervention is cost-effective, we grouped the …
[HTML][HTML] Orphan drugs offer larger health gains but less favorable cost-effectiveness than non-orphan drugs
JD Chambers, MC Silver, FC Berklein… - … internal medicine, 2020 - Springer
… drugs tend to be less cost-effective than non-orphan drugs. … a less stringent evidence
standard on orphan drugs than it … We did this because such values are interpreted differently …
standard on orphan drugs than it … We did this because such values are interpreted differently …